NASDAQ:CPIX Cumberland Pharmaceuticals (CPIX) Stock Price, News & Analysis → Forget AI, Imperium Is Expected to Grow 320,00% in 3 Years (From Banyan Hill Publishing) (Ad) Free CPIX Stock Alerts $1.76 +0.06 (+3.53%) (As of 04/26/2024 ET) Add Compare Share Share Today's Range$1.67▼$1.7950-Day Range$1.55▼$2.2152-Week Range$1.43▼$2.36Volume4,743 shsAverage Volume10,964 shsMarket Capitalization$24.96 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Get Cumberland Pharmaceuticals alerts: Email Address Ad Behind the MarketsBetter than Bitcoin? The Biotech Stock with 46,751% Potential4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.Get the name of the stock here >>> About Cumberland Pharmaceuticals Stock (NASDAQ:CPIX)Cumberland Pharmaceuticals Inc., a specialty pharmaceutical company, focuses on the acquisition, development, and commercialization of prescription products for hospital acute care, gastroenterology, and oncology in the United States and internationally. The company offers Acetadote, an injection for the treatment of acetaminophen poisoning; Caldolor, an injection for the treatment of pain and fever; Kristalose, a prescription laxative oral solution for the treatment of constipation; Omeclamox-Pak for the treatment of Helicobacter pylori infection and duodenal ulcer disease; Vaprisol, an injection for treating euvolemic and hypervolemic hyponatremia; Sancuso, an injection for the treatment of chemotherapy treatment; and Vibativ, an injection for the treatment of certain serious bacterial infections, including hospital-acquired and ventilator-associated bacterial pneumonia, as well as complicated skin and skin structure infections. It develops RediTrex injection for the treatment of active rheumatoid, juvenile idiopathic, and severe psoriatic arthritis, as well as disabling psoriasis. In addition, the company is developing ifetroban, a product candidate that is in phase II clinical trial for the treatment of aspirin-exacerbated respiratory disease, systemic sclerosis, and duchenne muscular dystrophy; and has completed phase II clinical trial for the treatment of hepatorenal syndrome and portal hypertension. Further, it develops a clinical program for the use of ifetroban to treat progressive fibrosing interstitial lung diseases. The company was incorporated in 1999 and is headquartered in Nashville, Tennessee.Read More CPIX Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart CPIX Stock News HeadlinesApril 27, 2024 | msn.comBipartisan support shown for small business funding in Cumberland Co.April 26, 2024 | msn.comCumberland County man pleads guilty to 'brutal' stabbing of female victimApril 27, 2024 | Weiss Ratings (Ad)Protect Yourself While There’s Still Time …The next step of the Fed's control is here. Section 702 of the Foreign Intelligence Surveillance Act was renewed for two more years and passed into law earlier this week. Allowing the Fed to tighten its grip on your personal privacy and freedom.April 26, 2024 | msn.comCumberland Valley school board member demands colleague resigns following controversyApril 26, 2024 | msn.comJury convicts former Cumberland teacher of child molestation countsApril 26, 2024 | msn.comCumberland County man pleads guilty to attempted murderApril 26, 2024 | msn.com6-year-old girl injured in Cumberland County drive-by shootingApril 26, 2024 | msn.comCumberland County DA responds to video of drug use, fights in PortlandApril 27, 2024 | Weiss Ratings (Ad)Protect Yourself While There’s Still Time …The next step of the Fed's control is here. Section 702 of the Foreign Intelligence Surveillance Act was renewed for two more years and passed into law earlier this week. Allowing the Fed to tighten its grip on your personal privacy and freedom.April 25, 2024 | msn.comMulti-vehicle crash shuts down part of I-83 in Cumberland CountyApril 25, 2024 | msn.com6-year-old girl shot during drive-by expected to make full recovery, Cumberland County sheriff saysApril 25, 2024 | msn.comLocal hoagie shop closing Cumberland Co. location; announces consolidationApril 25, 2024 | msn.comJuvenile injured in drive-by shooting on Pleasant View Drive, Cumberland County sheriff saysApril 25, 2024 | msn.comCumberland County deputies investigating overnight shooting on Pleasant View DriveApril 25, 2024 | yahoo.comEarly morning Cumberland County hotel fire causes evacuationsApril 25, 2024 | msn.comMaulik Pancholy allowed to speak at Cumberland Valley after emotional meetingApril 24, 2024 | msn.comAlumni, residents weigh in on Cumberland County Schools' plan to move E.E. Smith High SchoolApril 24, 2024 | msn.comCumberland Valley School Board to hold special meeting amid Maulik Pancholy cancellation backlashApril 24, 2024 | msn.comCumberland Valley School Board to hold special meeting on canceled speaker eventApril 24, 2024 | news.yahoo.comCumberland Valley School Board to hold special meeting on Pancholy speech; location changedApril 24, 2024 | msn.comCumberland County woman to receive Humane Society of United States award for creating 'Spay/Neuter Saves Lives' license platesApril 24, 2024 | msn.comSheriff's office warns Cumberland County residents of jury scamApril 24, 2024 | yahoo.comNew cases of chronic wasting disease found in deer in Cumberland CountyApril 24, 2024 | msn.comMan dies in stabbing at Cumberland County sports barApril 24, 2024 | msn.comCumberland County’s school funding winners and losersApril 24, 2024 | americanbankingnews.comCumberland Pharmaceuticals (NASDAQ:CPIX) Coverage Initiated by Analysts at StockNews.comApril 23, 2024 | msn.comCumberland Valley School Board to hold special meeting amid backlashSee More Headlines Receive CPIX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Cumberland Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings3/05/2024Today4/26/2024Next Earnings (Estimated)5/14/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Pharmaceutical preparations Sub-IndustryPharmaceuticals Current SymbolNASDAQ:CPIX CUSIP23077010 CIK1087294 Webwww.cumberlandpharma.com Phone(615) 255-0068Fax615-255-0094Employees91Year Founded1999Profitability EPS (Most Recent Fiscal Year)($0.44) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-6,280,000.00 Net Margins-15.87% Pretax Margin-15.89% Return on Equity6.84% Return on Assets2.70% Debt Debt-to-Equity Ratio0.44 Current Ratio1.28 Quick Ratio1.11 Sales & Book Value Annual Sales$39.55 million Price / Sales0.63 Cash Flow$0.76 per share Price / Cash Flow2.33 Book Value$1.96 per share Price / Book0.90Miscellaneous Outstanding Shares14,180,000Free Float8,038,000Market Cap$24.96 million OptionableOptionable Beta0.16 Social Links A Guide To High-Short-Interest StocksMarketBeat's analysts have just released their top five short plays for May 2024. Learn which stocks have the most short interest and how to trade them. Click the link below to see which companies made the list.Get This Free Report Key ExecutivesMr. A. J. Kazimi MBA (Age 66)Founder, Chairman, President & CEO Comp: $952.53kMr. John Michael Hamm (Age 68)VP & CFO Comp: $258.38kMr. James Lowrance Herman (Age 69)Executive VP of National Accounts & Chief Compliance Officer Comp: $372.27kMr. Chris T. Bitterman (Age 59)Vice President of Sales & Marketing Comp: $290.87kMr. Todd M. Anthony (Age 63)Vice President of Organizational Development Comp: $304.94kMs. Jean W. Marstiller (Age 74)Senior VP of Administrative Services & Corporate Secretary Comp: $282.17kMr. Adam S. Mostafa (Age 44)Managing Director Ms. Erin Smith GullSenior Corporate Relations AssociateMore ExecutivesKey CompetitorsAssembly BiosciencesNASDAQ:ASMBOncternal TherapeuticsNASDAQ:ONCTBiora TherapeuticsNASDAQ:BIORCytoMed TherapeuticsNASDAQ:GDTCBullfrog AINASDAQ:BFRGView All CompetitorsInstitutional OwnershipSimplex Trading LLCBought 300 shares on 2/2/2024Ownership: 0.000%View All Institutional Transactions CPIX Stock Analysis - Frequently Asked Questions How have CPIX shares performed in 2024? Cumberland Pharmaceuticals' stock was trading at $1.7917 at the beginning of the year. Since then, CPIX shares have decreased by 1.8% and is now trading at $1.76. View the best growth stocks for 2024 here. Are investors shorting Cumberland Pharmaceuticals? Cumberland Pharmaceuticals saw a drop in short interest in the month of March. As of March 31st, there was short interest totaling 17,000 shares, a drop of 16.7% from the March 15th total of 20,400 shares. Based on an average daily volume of 11,800 shares, the days-to-cover ratio is presently 1.4 days. Approximately 0.2% of the shares of the stock are sold short. View Cumberland Pharmaceuticals' Short Interest. When is Cumberland Pharmaceuticals' next earnings date? The company is scheduled to release its next quarterly earnings announcement on Tuesday, May 14th 2024. View our CPIX earnings forecast. How were Cumberland Pharmaceuticals' earnings last quarter? Cumberland Pharmaceuticals Inc. (NASDAQ:CPIX) posted its quarterly earnings data on Tuesday, March, 5th. The specialty pharmaceutical company reported ($0.12) EPS for the quarter. The specialty pharmaceutical company had revenue of $9.35 million for the quarter. Cumberland Pharmaceuticals had a negative net margin of 15.87% and a positive trailing twelve-month return on equity of 6.84%. What is A. J. Kazimi's approval rating as Cumberland Pharmaceuticals' CEO? 9 employees have rated Cumberland Pharmaceuticals Chief Executive Officer A. J. Kazimi on Glassdoor.com. A. J. Kazimi has an approval rating of 9% among the company's employees. This puts A. J. Kazimi in the bottom 10% of approval ratings compared to other CEOs of publicly-traded companies. What other stocks do shareholders of Cumberland Pharmaceuticals own? Based on aggregate information from My MarketBeat watchlists, some companies that other Cumberland Pharmaceuticals investors own include Fulcrum Therapeutics (FULC), VIVUS (VVUS), CymaBay Therapeutics (CBAY), Sorrento Therapeutics (SRNE), SCYNEXIS (SCYX), VBI Vaccines (VBIV), Akero Therapeutics (AKRO), Cerecor (CERC), Xeris Biopharma (XERS). How do I buy shares of Cumberland Pharmaceuticals? Shares of CPIX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:CPIX) was last updated on 4/27/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThese AI trades triggered this morning (545% return)Prosper Trading AcademyHe Is Giving Away BitcoinCrypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithFed launches fourth dollar overhaulStansberry ResearchBiden out June 13; Kamala won’t replace him?Paradigm PressMan Who Predicted 2008: “This Will be Worse.”AltimetryExposed: 10 CENT Crypto to Explode April 20th?True Market Insiders Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cumberland Pharmaceuticals Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.